搜尋結果
Bausch Health investors are left in a holding pattern as 2 major overhangs remain unresolved
CNBC· 4 日前Bausch Health Companies on Tuesday morning reported first-quarter top- and bottom-line misses — ...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg· 3 日前Have a confidential tip for our reporters? Novo Nordisk A/S shares fell as
How To Find A Balance Between Corporate Engagement and Customer Outrage
Forbes· 1 日前Smart policies have made the American economy, in a word, exceptional. Forbes’ Mitchell ...
Here Are the Obesity Drug Hopefuls Vying to Unseat Ozempic, Zepbound
Bloomberg· 3 日前Insatiable demand for weight-loss drugs has made the market so feverish that any positive ... ...
Real. Trial. Lawyers. Launch New Firm — SCHONBUCH HALLISSY LLP to Open Brentwood Office
Bastillepost· 5 日前The U.S. Drug Enforcement Administration is moving toward reclassifying marijuana ...
Pot Stocks Surge on Report DEA Set to Reclassify Marijuana
Bloomberg· 6 日前Have a confidential tip for our reporters? Shares of cannabis-related companies jumped Tuesday ...
Global health heavyweights team up for climate, disease funding
Reuters· 9 小時前Three of the biggest global health funders have joined forces for the first time in ... ...
Forbes Daily: Weed Stocks Light Up After DEA Reclassification
Forbes· 5 日前The U.S. Drug Enforcement Administration will end its ban on cannabis ...
There Is Broad Appeal for Cannabis Reform: Trulieve CEO
Bloomberg· 4 日前Kim Rivers, chairman, chief executive officer and founder of Trulieve Cannabis, discusses the r ...
Medicare Says It Expects To Spend $3.5 Billion In 2025 On Alzheimer’s Drug Leqembi, But This Is ...
Forbes· 3 日前There were several explicitly stated assumptions made by CMS in its recent assessment of the co ...